Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates
...view more
Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.
Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.
Key Features
Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive.
Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations.
Includes a timely section on innovative future therapies.
https://www.uk.elsevierhealth.com/her2-positive-breast-cancer-9780323581226.html91714HER2-Positive Breast Cancerhttps://www.uk.elsevierhealth.com/media/catalog/product/9/7/9780323581226_6.jpg66.5973.99GBPInStock/Medicine and Surgery/Oncology/Books100505255039<p>Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.</p> <p>Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.</p>00add-to-cart97803235812262018ProfessionalBy Sara Hurvitz, MD and Kelly McCann20191Book191w x 235hApprox. 100 illustrations (100 in full color)Elsevier2642 Aug 2018PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSBy <STRONG>Sara Hurvitz</STRONG>, MD and <STRONG>Kelly McCann</STRONG>BooksNoNoNoNoPlease SelectPlease SelectPlease Select